Medical Doctor Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Brian Szwarc

Plastic Surgery within the Head & Neck Thomasville, GA Medical Doctor

NPI 1366553349 CMS profile 1000109

100 Mimosa Dr, 3Rd Floor, Thomasville, GA 31792

Open in the dashboard

General payments

$92

3 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Szwarc of Thomasville, GA is reported in the CMS Open Payments database as having received $92 across 3 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 9th percentile of Plastic Surgery within the Head & Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $57 2
2023 General $35 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Szwarc
  • Plastic Surgery within the Head & Neck median
  • Middle half of Plastic Surgery within the Head & Neck
  • National median

In program year 2025, general payments to Brian Szwarc were reported at $57. Among 399 Plastic Surgery within the Head & Neck profiles paid that year, the median was $237 and the middle half received between $103 and $520.

Show as a table
Year Brian Szwarc Plastic Surgery within the Head & Neck median Middle half National median
2019 $0 $200 $82–$550 $163
2020 $0 $120 $46–$330 $114
2021 $0 $166 $60–$382 $132
2022 $0 $208 $83–$530 $149
2023 $35 $202 $77–$538 $160
2024 $0 $260 $99–$645 $164
2025 $57 $237 $103–$520 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Integra LifeSciences Corporation $35 1 payment
  2. Cochlear Americas $32 1 payment
  3. Inspire Medical Systems, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Food and Beverage $92 3 payments
Products named General payments · program years 2023–2025
  1. INTEGRA $35 1 payment
  2. CODMAN ISOCOOL AHT $35 1 payment
  3. MICROFRANCE $35 1 payment
  4. INSTRUMENTS-ORTHOPEDIC $35 1 payment
  5. INTEGRA DUO $35 1 payment
  6. Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode $32 1 payment
  7. BAHA $32 1 payment
  8. OSIA OSI300 IMPLANT $32 1 payment
  9. INSPIRE $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

533

Median for Otolaryngology: 297

Drug cost

$8,031

Median for Otolaryngology: $6,314

Branded share of claims

12%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ipratropium Bromide Generic 130 $3,865
Carbamazepine Generic 19 $662
Mometasone Furoate Generic 57 $627
Omeprazole Generic 57 $474
Azelastine Hcl Generic 20 $468
Fluticasone Propionate Generic 44 $438
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 36 $259
Ofloxacin Generic 15 $211
Cephalexin Generic 42 $194
Clotrimazole Generic 16 $182

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$133,535

Medicare's payments for the services billed

Medicare patients

462

Average age 76

Services billed

4,507

244 women, 218 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 36%
Chronic kidney disease 31%
Diabetes 29%
Heart failure 27%
Atrial fibrillation 24%
Depression 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

3 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery within the Head & Neck in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record